ANTIARRHYTHMIC DRUG-INTERACTIONS - ARE THEY IMPORTANT

被引:4
作者
JAILLON, P
机构
关键词
D O I
10.1093/eurheartj/8.suppl_A.127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:127 / 132
页数:6
相关论文
共 48 条
[1]  
BAKER BJ, 1985, CIRCULATION, V72, P170
[2]   DOSE-DEPENDENT EFFECT OF CIMETIDINE ON PHENYTOIN KINETICS [J].
BARTLE, WR ;
WALKER, SE ;
SHAPERO, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :649-655
[3]   QUINIDINE-DIGOXIN INTERACTION - CARDIAC EFFICACY OF ELEVATED SERUM DIGOXIN CONCENTRATION [J].
BELZ, GG ;
DOERING, W ;
AUST, PE ;
HEINZ, M ;
MATTHEWS, J ;
SCHNEIDER, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) :548-554
[4]   INTERACTION BETWEEN DIGOXIN AND CALCIUM-ANTAGONISTS AND ANTI-ARRHYTHMIC DRUGS [J].
BELZ, GG ;
DOERING, W ;
MUNKES, R ;
MATTHEWS, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) :410-417
[5]   DRUG-INTERACTIONS IN ANTIARRHYTHMIC THERAPY [J].
BIGGER, JT ;
GIARDINA, EGV .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 427 (JUN) :140-162
[6]   THE INTERACTION OF MEXILETINE WITH OTHER CARDIOVASCULAR DRUGS [J].
BIGGER, JT .
AMERICAN HEART JOURNAL, 1984, 107 (05) :1079-1085
[7]   CIMETIDINE INHIBITS RENAL PROCAINAMIDE CLEARANCE [J].
CHRISTIAN, CD ;
MEREDITH, CG ;
SPEEG, KV .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) :221-227
[8]   LIDOCAINE ELIMINATION - EFFECTS OF METOPROLOL AND OF PROPRANOLOL [J].
CONRAD, KA ;
BYERS, JM ;
FINLEY, PR ;
BURNHAM, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) :133-138
[9]   REDUCTION OF DIGOXIN EFFECT DURING THE DIGOXIN-QUINIDINE INTERACTION [J].
DAS, G ;
BARR, CE ;
CARLSON, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (03) :317-321